Sarah Jessica Parker Cuts Ties with EpiPen Over Price Hike – Kveller
Skip to Content Skip to Footer


Sarah Jessica Parker Cuts Ties with EpiPen Over Price Hike

Sarah Jessica Parker will no longer be associated with the drugmaker Mylan, who manufactures the EpiPen, as a result of the exorbitant price hike. We previously reported the price of the EpiPen twin pack rose to $608 earlier this year, in comparison to $57 in 2007.

On her Instagram, Parker posted a message stating:

A photo posted by SJP (@sarahjessicaparker) on

Since her 13-year-old son James has severe peanut and hazelnut allergies, Parker was previously part of a campaign with Mylan, which is why this means so much to her, stating how she hopes “they will seriously reconsider the outpouring of voices of those millions of people who are dependent on the device, and take swift action to lower the cost to be more affordable for whom it is a life-saving necessity.”

While Mylan did announce Thursday it would offer discounts for the medication, including coupons covering up to $300 “for patients in health plans who face higher out-of-pocket costs,” it’s not enough. The price increase seems unnecessary. It doesn’t help that Mylan CEO Heather Bresch has seen a 671% salary increase over the past eight years, bringing her current annual salary to $19 million (plus perks, of course).

I’m glad celebrities and public figures like Sarah Jessica Parker are coming out in defense of families everywhere–because allowing a drug company to take advantage of people who have severe allergies is not only unethical, but simply gross. Is this the kind of behavior we want to stand by as a country?

Sadly, many of us don’t have the level of influence Parker does, but this is precisely why more people like her need to make a stand.

Read More:

I Took a Vacation By Myself And It Wasn’t What I Expected

4 Things You Should Do When Your Friend Loses a Spouse

Hilarious Dad Uses ‘Pokemon Go’ to Persuade His Kids to Do Chores

Skip to Banner / Top Skip to Content